Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01753479 · ClinicalTrials.gov registry record · NA
Spectroscopy From Duodenum
A NA study of Pancreatic Adenocarcinoma, sponsored by Olympus Corporation.
- Completed
- Registry status
- NA
- Development phase
- 445
- Enrollment target
- 4
- Study locations
NCT01753479: Completed NA study of Pancreatic Adenocarcinoma, sponsored by Olympus Corporation.
NCT01753479 is a NA study of Pancreatic Adenocarcinoma that has completed, run by Olympus Corporation. The registered enrollment target is 445 participants, below the 99,458-participant average among 62 other Pancreatic Adenocarcinoma trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01753479, a NA study of Pancreatic Adenocarcinoma, has completed, sponsored by Olympus Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 445 participants
- Enrollment target
- 4
- Study locations
Study Summary
Purpose of this study is to understand the clinical feasibility of duodenal spectroscopy to adenocarcinoma patients.
Primary Outcome
To clarify that there is the statistically-significant difference between two cohorts.
Conditions Studied
Interventions
- OTHER Spectroscopy device
Study Locations (4)
Florida
- Mayo Clinic Florida - Jacksonville
Texas
- The University of Texas M. D. Anderson Cancer Center - Houston
Brussels Capital
- Hôpital Erasme - Brussels
Lazio
- Università Cattolica del Sacro Cuore - Rome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-06-30 |
| Phase | NA |
What the finished NCT01753479 record still lists
NCT01753479 is an interventional study that assigns participants to a tested intervention. The registered 445 participants enrollment target is mid-sized for trials with a published cap, below the 99,458-participant average among 62 other Pancreatic Adenocarcinoma trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Pancreatic Adenocarcinoma appearing as the primary indexed condition, and to 1 intervention - of which Spectroscopy device is the first listed.
NCT01753479 reports a single indexed study location in Florida, Texas, Brussels Capital.
Frequently Asked Questions
What is clinical trial NCT01753479 about?
NCT01753479 is a clinical study titled "Spectroscopy From Duodenum". Purpose of this study is to understand the clinical feasibility of duodenal spectroscopy to adenocarcinoma patients.
What is the current status of trial NCT01753479?
This trial is currently completed. It is a NA study. The enrollment target is 445 participants. The study started on 2013-01. Estimated completion is 2016-06-30.
What conditions does trial NCT01753479 study?
This clinical trial studies the following conditions: Pancreatic Adenocarcinoma.
What interventions are being tested in trial NCT01753479?
The interventions under investigation include: Spectroscopy device (OTHER).
Who is sponsoring clinical trial NCT01753479?
This trial is sponsored by Olympus Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01753479 being conducted?
This trial has 4 study locations across Florida, Texas, Brussels Capital, Lazio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01753479's enrollment target sits among peer trials
445 10th of 62 higher than 53 of 62 other Pancreatic Adenocarcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Adenocarcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
RECRUITING · NA
-
Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study
ACTIVE NOT RECRUITING · NA
-
Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis
COMPLETED · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia